img

Global Cannabinoid-based Antitumor Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Cannabinoid-based Antitumor Drug Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Cannabinoid-based Antitumor Drug Market
The global Cannabinoid-based Antitumor Drug market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Cannabinoid-based Antitumor Drug is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Cannabinoid-based Antitumor Drug is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Cannabinoid-based Antitumor Drug is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key companies of Cannabinoid-based Antitumor Drug include Cannabics Inc., Tikun Olam, Jay Pharma, GW Pharmaceuticals, Medicanja Ltd and Valeant Pharmaceuticals, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Cannabinoid-based Antitumor Drug market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Cannabinoid-based Antitumor Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cannabinoid-based Antitumor Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cannabinoid-based Antitumor Drug revenue, market share and industry ranking of main companies, data from 2018 to 2024. Identification of the major stakeholders in the global Cannabinoid-based Antitumor Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2034. Evaluation and forecast the market size for Cannabinoid-based Antitumor Drug revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Cannabics Inc., Tikun Olam, Jay Pharma, GW Pharmaceuticals, Medicanja Ltd and Valeant Pharmaceuticals, etc.



By Company


Cannabics Inc.
Tikun Olam
Jay Pharma
GW Pharmaceuticals
Medicanja Ltd
Valeant Pharmaceuticals
Segment by Type
Chewing Medicine
Lozenge
Other

Segment by Application


Clinics
Hospitals
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of Cannabinoid-based Antitumor Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of Cannabinoid-based Antitumor Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cannabinoid-based Antitumor Drug revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cannabinoid-based Antitumor Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Chewing Medicine
1.2.3 Lozenge
1.2.4 Other
1.3 Market by Application
1.3.1 Global Cannabinoid-based Antitumor Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cannabinoid-based Antitumor Drug Market Perspective (2018-2034)
2.2 Global Cannabinoid-based Antitumor Drug Growth Trends by Region
2.2.1 Cannabinoid-based Antitumor Drug Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Cannabinoid-based Antitumor Drug Historic Market Size by Region (2018-2024)
2.2.3 Cannabinoid-based Antitumor Drug Forecasted Market Size by Region (2024-2034)
2.3 Cannabinoid-based Antitumor Drug Market Dynamics
2.3.1 Cannabinoid-based Antitumor Drug Industry Trends
2.3.2 Cannabinoid-based Antitumor Drug Market Drivers
2.3.3 Cannabinoid-based Antitumor Drug Market Challenges
2.3.4 Cannabinoid-based Antitumor Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Cannabinoid-based Antitumor Drug by Players
3.1.1 Global Cannabinoid-based Antitumor Drug Revenue by Players (2018-2024)
3.1.2 Global Cannabinoid-based Antitumor Drug Revenue Market Share by Players (2018-2024)
3.2 Global Cannabinoid-based Antitumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cannabinoid-based Antitumor Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Cannabinoid-based Antitumor Drug Market Concentration Ratio
3.4.1 Global Cannabinoid-based Antitumor Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cannabinoid-based Antitumor Drug Revenue in 2022
3.5 Global Key Players of Cannabinoid-based Antitumor Drug Head office and Area Served
3.6 Global Key Players of Cannabinoid-based Antitumor Drug, Product and Application
3.7 Global Key Players of Cannabinoid-based Antitumor Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cannabinoid-based Antitumor Drug Breakdown Data by Type
4.1 Global Cannabinoid-based Antitumor Drug Historic Market Size by Type (2018-2024)
4.2 Global Cannabinoid-based Antitumor Drug Forecasted Market Size by Type (2024-2034)
5 Cannabinoid-based Antitumor Drug Breakdown Data by Application
5.1 Global Cannabinoid-based Antitumor Drug Historic Market Size by Application (2018-2024)
5.2 Global Cannabinoid-based Antitumor Drug Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Cannabinoid-based Antitumor Drug Market Size (2018-2034)
6.2 North America Cannabinoid-based Antitumor Drug Market Size by Type
6.2.1 North America Cannabinoid-based Antitumor Drug Market Size by Type (2018-2024)
6.2.2 North America Cannabinoid-based Antitumor Drug Market Size by Type (2024-2034)
6.2.3 North America Cannabinoid-based Antitumor Drug Market Share by Type (2018-2034)
6.3 North America Cannabinoid-based Antitumor Drug Market Size by Application
6.3.1 North America Cannabinoid-based Antitumor Drug Market Size by Application (2018-2024)
6.3.2 North America Cannabinoid-based Antitumor Drug Market Size by Application (2024-2034)
6.3.3 North America Cannabinoid-based Antitumor Drug Market Share by Application (2018-2034)
6.4 North America Cannabinoid-based Antitumor Drug Market Size by Country
6.4.1 North America Cannabinoid-based Antitumor Drug Market Size by Country: 2018 VS 2022 VS 2034
6.4.2 North America Cannabinoid-based Antitumor Drug Market Size by Country (2018-2024)
6.4.3 North America Cannabinoid-based Antitumor Drug Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Cannabinoid-based Antitumor Drug Market Size (2018-2034)
7.2 Europe Cannabinoid-based Antitumor Drug Market Size by Type
7.2.1 Europe Cannabinoid-based Antitumor Drug Market Size by Type (2018-2024)
7.2.2 Europe Cannabinoid-based Antitumor Drug Market Size by Type (2024-2034)
7.2.3 Europe Cannabinoid-based Antitumor Drug Market Share by Type (2018-2034)
7.3 Europe Cannabinoid-based Antitumor Drug Market Size by Application
7.3.1 Europe Cannabinoid-based Antitumor Drug Market Size by Application (2018-2024)
7.3.2 Europe Cannabinoid-based Antitumor Drug Market Size by Application (2024-2034)
7.3.3 Europe Cannabinoid-based Antitumor Drug Market Share by Application (2018-2034)
7.4 Europe Cannabinoid-based Antitumor Drug Market Size by Country
7.4.1 Europe Cannabinoid-based Antitumor Drug Market Size by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Cannabinoid-based Antitumor Drug Market Size by Country (2018-2024)
7.4.3 Europe Cannabinoid-based Antitumor Drug Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Cannabinoid-based Antitumor Drug Market Size (2018-2034)
8.2 China Cannabinoid-based Antitumor Drug Market Size by Type
8.2.1 China Cannabinoid-based Antitumor Drug Market Size by Type (2018-2024)
8.2.2 China Cannabinoid-based Antitumor Drug Market Size by Type (2024-2034)
8.2.3 China Cannabinoid-based Antitumor Drug Market Share by Type (2018-2034)
8.3 China Cannabinoid-based Antitumor Drug Market Size by Application
8.3.1 China Cannabinoid-based Antitumor Drug Market Size by Application (2018-2024)
8.3.2 China Cannabinoid-based Antitumor Drug Market Size by Application (2024-2034)
8.3.3 China Cannabinoid-based Antitumor Drug Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Cannabinoid-based Antitumor Drug Market Size (2018-2034)
9.2 Asia Cannabinoid-based Antitumor Drug Market Size by Type
9.2.1 Asia Cannabinoid-based Antitumor Drug Market Size by Type (2018-2024)
9.2.2 Asia Cannabinoid-based Antitumor Drug Market Size by Type (2024-2034)
9.2.3 Asia Cannabinoid-based Antitumor Drug Market Share by Type (2018-2034)
9.3 Asia Cannabinoid-based Antitumor Drug Market Size by Application
9.3.1 Asia Cannabinoid-based Antitumor Drug Market Size by Application (2018-2024)
9.3.2 Asia Cannabinoid-based Antitumor Drug Market Size by Application (2024-2034)
9.3.3 Asia Cannabinoid-based Antitumor Drug Market Share by Application (2018-2034)
9.4 Asia Cannabinoid-based Antitumor Drug Market Size by Region
9.4.1 Asia Cannabinoid-based Antitumor Drug Market Size by Region: 2018 VS 2022 VS 2034
9.4.2 Asia Cannabinoid-based Antitumor Drug Market Size by Region (2018-2024)
9.4.3 Asia Cannabinoid-based Antitumor Drug Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Market Size by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Cannabics Inc.
11.1.1 Cannabics Inc. Company Details
11.1.2 Cannabics Inc. Business Overview
11.1.3 Cannabics Inc. Cannabinoid-based Antitumor Drug Introduction
11.1.4 Cannabics Inc. Revenue in Cannabinoid-based Antitumor Drug Business (2018-2024)
11.1.5 Cannabics Inc. Recent Developments
11.2 Tikun Olam
11.2.1 Tikun Olam Company Details
11.2.2 Tikun Olam Business Overview
11.2.3 Tikun Olam Cannabinoid-based Antitumor Drug Introduction
11.2.4 Tikun Olam Revenue in Cannabinoid-based Antitumor Drug Business (2018-2024)
11.2.5 Tikun Olam Recent Developments
11.3 Jay Pharma
11.3.1 Jay Pharma Company Details
11.3.2 Jay Pharma Business Overview
11.3.3 Jay Pharma Cannabinoid-based Antitumor Drug Introduction
11.3.4 Jay Pharma Revenue in Cannabinoid-based Antitumor Drug Business (2018-2024)
11.3.5 Jay Pharma Recent Developments
11.4 GW Pharmaceuticals
11.4.1 GW Pharmaceuticals Company Details
11.4.2 GW Pharmaceuticals Business Overview
11.4.3 GW Pharmaceuticals Cannabinoid-based Antitumor Drug Introduction
11.4.4 GW Pharmaceuticals Revenue in Cannabinoid-based Antitumor Drug Business (2018-2024)
11.4.5 GW Pharmaceuticals Recent Developments
11.5 Medicanja Ltd
11.5.1 Medicanja Ltd Company Details
11.5.2 Medicanja Ltd Business Overview
11.5.3 Medicanja Ltd Cannabinoid-based Antitumor Drug Introduction
11.5.4 Medicanja Ltd Revenue in Cannabinoid-based Antitumor Drug Business (2018-2024)
11.5.5 Medicanja Ltd Recent Developments
11.6 Valeant Pharmaceuticals
11.6.1 Valeant Pharmaceuticals Company Details
11.6.2 Valeant Pharmaceuticals Business Overview
11.6.3 Valeant Pharmaceuticals Cannabinoid-based Antitumor Drug Introduction
11.6.4 Valeant Pharmaceuticals Revenue in Cannabinoid-based Antitumor Drug Business (2018-2024)
11.6.5 Valeant Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cannabinoid-based Antitumor Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Chewing Medicine
Table 3. Key Players of Lozenge
Table 4. Key Players of Other
Table 5. Global Cannabinoid-based Antitumor Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 6. Global Cannabinoid-based Antitumor Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 7. Global Cannabinoid-based Antitumor Drug Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Cannabinoid-based Antitumor Drug Market Share by Region (2018-2024)
Table 9. Global Cannabinoid-based Antitumor Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Cannabinoid-based Antitumor Drug Market Share by Region (2024-2034)
Table 11. Cannabinoid-based Antitumor Drug Market Trends
Table 12. Cannabinoid-based Antitumor Drug Market Drivers
Table 13. Cannabinoid-based Antitumor Drug Market Challenges
Table 14. Cannabinoid-based Antitumor Drug Market Restraints
Table 15. Global Cannabinoid-based Antitumor Drug Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Cannabinoid-based Antitumor Drug Revenue Share by Players (2018-2024)
Table 17. Global Top Cannabinoid-based Antitumor Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabinoid-based Antitumor Drug as of 2022)
Table 18. Global Cannabinoid-based Antitumor Drug Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Cannabinoid-based Antitumor Drug Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Cannabinoid-based Antitumor Drug, Headquarters and Area Served
Table 21. Global Key Players of Cannabinoid-based Antitumor Drug, Product and Application
Table 22. Global Key Players of Cannabinoid-based Antitumor Drug, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cannabinoid-based Antitumor Drug Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Cannabinoid-based Antitumor Drug Revenue Market Share by Type (2018-2024)
Table 26. Global Cannabinoid-based Antitumor Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Cannabinoid-based Antitumor Drug Revenue Market Share by Type (2024-2034)
Table 28. Global Cannabinoid-based Antitumor Drug Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Cannabinoid-based Antitumor Drug Revenue Share by Application (2018-2024)
Table 30. Global Cannabinoid-based Antitumor Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Cannabinoid-based Antitumor Drug Revenue Share by Application (2024-2034)
Table 32. North America Cannabinoid-based Antitumor Drug Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Cannabinoid-based Antitumor Drug Market Size by Type (2024-2034) & (US$ Million)
Table 34. North America Cannabinoid-based Antitumor Drug Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Cannabinoid-based Antitumor Drug Market Size by Application (2024-2034) & (US$ Million)
Table 36. North America Cannabinoid-based Antitumor Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 37. North America Cannabinoid-based Antitumor Drug Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Cannabinoid-based Antitumor Drug Market Size by Country (2024-2034) & (US$ Million)
Table 39. Europe Cannabinoid-based Antitumor Drug Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Cannabinoid-based Antitumor Drug Market Size by Type (2024-2034) & (US$ Million)
Table 41. Europe Cannabinoid-based Antitumor Drug Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Cannabinoid-based Antitumor Drug Market Size by Application (2024-2034) & (US$ Million)
Table 43. Europe Cannabinoid-based Antitumor Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 44. Europe Cannabinoid-based Antitumor Drug Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Cannabinoid-based Antitumor Drug Market Size by Country (2024-2034) & (US$ Million)
Table 46. China Cannabinoid-based Antitumor Drug Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Cannabinoid-based Antitumor Drug Market Size by Type (2024-2034) & (US$ Million)
Table 48. China Cannabinoid-based Antitumor Drug Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Cannabinoid-based Antitumor Drug Market Size by Application (2024-2034) & (US$ Million)
Table 50. Asia Cannabinoid-based Antitumor Drug Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Cannabinoid-based Antitumor Drug Market Size by Type (2024-2034) & (US$ Million)
Table 52. Asia Cannabinoid-based Antitumor Drug Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Cannabinoid-based Antitumor Drug Market Size by Application (2024-2034) & (US$ Million)
Table 54. Asia Cannabinoid-based Antitumor Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 55. Asia Cannabinoid-based Antitumor Drug Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Cannabinoid-based Antitumor Drug Market Size by Region (2024-2034) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Market Size by Type (2024-2034) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Market Size by Application (2024-2034) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 62. Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Market Size by Country (2024-2034) & (US$ Million)
Table 64. Cannabics Inc. Company Details
Table 65. Cannabics Inc. Business Overview
Table 66. Cannabics Inc. Cannabinoid-based Antitumor Drug Product
Table 67. Cannabics Inc. Revenue in Cannabinoid-based Antitumor Drug Business (2018-2024) & (US$ Million)
Table 68. Cannabics Inc. Recent Developments
Table 69. Tikun Olam Company Details
Table 70. Tikun Olam Business Overview
Table 71. Tikun Olam Cannabinoid-based Antitumor Drug Product
Table 72. Tikun Olam Revenue in Cannabinoid-based Antitumor Drug Business (2018-2024) & (US$ Million)
Table 73. Tikun Olam Recent Developments
Table 74. Jay Pharma Company Details
Table 75. Jay Pharma Business Overview
Table 76. Jay Pharma Cannabinoid-based Antitumor Drug Product
Table 77. Jay Pharma Revenue in Cannabinoid-based Antitumor Drug Business (2018-2024) & (US$ Million)
Table 78. Jay Pharma Recent Developments
Table 79. GW Pharmaceuticals Company Details
Table 80. GW Pharmaceuticals Business Overview
Table 81. GW Pharmaceuticals Cannabinoid-based Antitumor Drug Product
Table 82. GW Pharmaceuticals Revenue in Cannabinoid-based Antitumor Drug Business (2018-2024) & (US$ Million)
Table 83. GW Pharmaceuticals Recent Developments
Table 84. Medicanja Ltd Company Details
Table 85. Medicanja Ltd Business Overview
Table 86. Medicanja Ltd Cannabinoid-based Antitumor Drug Product
Table 87. Medicanja Ltd Revenue in Cannabinoid-based Antitumor Drug Business (2018-2024) & (US$ Million)
Table 88. Medicanja Ltd Recent Developments
Table 89. Valeant Pharmaceuticals Company Details
Table 90. Valeant Pharmaceuticals Business Overview
Table 91. Valeant Pharmaceuticals Cannabinoid-based Antitumor Drug Product
Table 92. Valeant Pharmaceuticals Revenue in Cannabinoid-based Antitumor Drug Business (2018-2024) & (US$ Million)
Table 93. Valeant Pharmaceuticals Recent Developments
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cannabinoid-based Antitumor Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 2. Global Cannabinoid-based Antitumor Drug Market Share by Type: 2022 VS 2034
Figure 3. Chewing Medicine Features
Figure 4. Lozenge Features
Figure 5. Other Features
Figure 6. Global Cannabinoid-based Antitumor Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Cannabinoid-based Antitumor Drug Market Share by Application: 2022 VS 2034
Figure 8. Clinics Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Others Case Studies
Figure 11. Cannabinoid-based Antitumor Drug Report Years Considered
Figure 12. Global Cannabinoid-based Antitumor Drug Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Cannabinoid-based Antitumor Drug Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Cannabinoid-based Antitumor Drug Market Share by Region: 2022 VS 2034
Figure 15. Global Cannabinoid-based Antitumor Drug Market Share by Players in 2022
Figure 16. Global Top Cannabinoid-based Antitumor Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabinoid-based Antitumor Drug as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Cannabinoid-based Antitumor Drug Revenue in 2022
Figure 18. North America Cannabinoid-based Antitumor Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Cannabinoid-based Antitumor Drug Market Share by Type (2018-2034)
Figure 20. North America Cannabinoid-based Antitumor Drug Market Share by Application (2018-2034)
Figure 21. North America Cannabinoid-based Antitumor Drug Market Share by Country (2018-2034)
Figure 22. United States Cannabinoid-based Antitumor Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Canada Cannabinoid-based Antitumor Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Cannabinoid-based Antitumor Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 25. Europe Cannabinoid-based Antitumor Drug Market Share by Type (2018-2034)
Figure 26. Europe Cannabinoid-based Antitumor Drug Market Share by Application (2018-2034)
Figure 27. Europe Cannabinoid-based Antitumor Drug Market Share by Country (2018-2034)
Figure 28. Germany Cannabinoid-based Antitumor Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. France Cannabinoid-based Antitumor Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. U.K. Cannabinoid-based Antitumor Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Italy Cannabinoid-based Antitumor Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Russia Cannabinoid-based Antitumor Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Nordic Countries Cannabinoid-based Antitumor Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. China Cannabinoid-based Antitumor Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 35. China Cannabinoid-based Antitumor Drug Market Share by Type (2018-2034)
Figure 36. China Cannabinoid-based Antitumor Drug Market Share by Application (2018-2034)
Figure 37. Asia Cannabinoid-based Antitumor Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 38. Asia Cannabinoid-based Antitumor Drug Market Share by Type (2018-2034)
Figure 39. Asia Cannabinoid-based Antitumor Drug Market Share by Application (2018-2034)
Figure 40. Asia Cannabinoid-based Antitumor Drug Market Share by Region (2018-2034)
Figure 41. Japan Cannabinoid-based Antitumor Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. South Korea Cannabinoid-based Antitumor Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. China Taiwan Cannabinoid-based Antitumor Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Southeast Asia Cannabinoid-based Antitumor Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. India Cannabinoid-based Antitumor Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Australia Cannabinoid-based Antitumor Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Market Share by Type (2018-2034)
Figure 49. Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Market Share by Application (2018-2034)
Figure 50. Middle East, Africa, and Latin America Cannabinoid-based Antitumor Drug Market Share by Country (2018-2034)
Figure 51. Brazil Cannabinoid-based Antitumor Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 52. Mexico Cannabinoid-based Antitumor Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 53. Turkey Cannabinoid-based Antitumor Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 54. Saudi Arabia Cannabinoid-based Antitumor Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 55. Israel Cannabinoid-based Antitumor Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 56. GCC Countries Cannabinoid-based Antitumor Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 57. Cannabics Inc. Revenue Growth Rate in Cannabinoid-based Antitumor Drug Business (2018-2024)
Figure 58. Tikun Olam Revenue Growth Rate in Cannabinoid-based Antitumor Drug Business (2018-2024)
Figure 59. Jay Pharma Revenue Growth Rate in Cannabinoid-based Antitumor Drug Business (2018-2024)
Figure 60. GW Pharmaceuticals Revenue Growth Rate in Cannabinoid-based Antitumor Drug Business (2018-2024)
Figure 61. Medicanja Ltd Revenue Growth Rate in Cannabinoid-based Antitumor Drug Business (2018-2024)
Figure 62. Valeant Pharmaceuticals Revenue Growth Rate in Cannabinoid-based Antitumor Drug Business (2018-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries